Formulation Development
FORMULATION DEVELOPMENT WHITE PAPERS & ARTICLES
-
Expert Q&A: Navigating Complexity In Modern Small Molecule Development
Small molecules are growing larger, more potent, and more structurally complex while timelines compress. That combination reshapes scale-up, outsourcing relationships, and the criteria for choosing a manufacturing partner.
-
A Connected Approach To OSD Development
See how an integrated OSD development strategy can identify risks early, strengthen process understanding and prepare products for scale-up, tech transfer and commercialization.
-
Is Your API Right For A Soft Gel Capsule?
Soft gel delivery systems can enhance bioavailability, enable controlled release, support combination dosing, and handle potent compounds while improving stability and patient adherence.
-
How A CDMO Overcomes Soft Gel Formulation Challenges
Softgel development demands careful control of shell properties, liquid fills, and stability. Overcoming formulation challenges improves drug delivery, bioavailability, and shelf life.
-
Oral Solutions & Suspensions: The Art Of Pharmacy
Oral liquid formulations improve accessibility and dosing flexibility. Learn how developers overcome stability, taste-masking, and manufacturing challenges.
FORMULATION DEVELOPMENT APPLICATIONS & STUDIES
-
Turning A "Brick Dust" Compound Into A Clinically Viable Oral Formulation
Advanced wet milling and particle stabilization improve solubility, enhance bioavailability, and support scalable manufacturing for complex oral drug development programs.
-
Creating A New Dosage Form From An Approved Drug For A New Rare Disease
Advancing approved drugs into new indications requires smart formulation, strong quality controls, and regulatory expertise to overcome challenges and accelerate patient access.
-
Long-Acting GnRH Antagonist For Advanced Prostate Cancer
Achieve rapid testosterone suppression for 6+ months with a novel low-volume subcutaneous depot formulation, eliminating the initial surge and offering a new approach for advanced prostate cancer treatment.
-
Why Early Device Decisions Matter: How Immunovant Accelerated Its Program
Deferring autoinjector selection can seem to preserve flexibility, yet it often moves constraints downstream. Integrating the device during Phase IIb changed one program's timeline and removed bridging work.
-
Using Human-Centered Engineering To Improve HPLC Solvent Handling
Real-world HPLC workflows show how closed-system solvent handling can address contamination, downtime, and waste across laboratory settings.
FORMULATION DEVELOPMENT SOLUTIONS
- Continuous Flow
- HyClone™ Prime Expression Medium
- A High-Purity Excipient Suitable For High-Risk Vaccine Applications
- Speed, Scale, And Supply With Innovative Cell Culture Solutions
- LABIO 4.0 Marino Golinelli R&D Pharmaceutical Center
- Scaling Difficult Chemistry Without Site Transfers
- Multi-Mode Microplate Reader
- The Way Forward In Antibody Therapeutics Purification
- The In Vitro Model Redefining Drug Discovery And Development
- Molecule To Cure. Fast.
PHARMACEUTICAL AND FORMULATION DEVELOPMENT NEWS
- Lonza Signs Agreement To Acquire US CDMO Network From Merck KGaA, Darmstadt, Germany, And Significantly Expands Its US Presence
- Bracco To Build New Injectable Drug Manufacturing Facility In North Carolina
- Lonza Further Expands Bioconjugation Manufacturing To Support Growing ADC Demand
- ROSS Portable High Shear Mixing System
- Ardena Launches Online Biomarker Catalogue: 228 Markers, One Quote Request
- Meissner Hosts Ribbon Cutting Ceremony For X-Ray Irradiation Services And Breaks Ground On Phase 2 Of Its Athens, Georgia, U.S.A. Campus
- Global Pharma Manufacturing Community Meets In Berlin For PHARMAP 2027
- LGM Pharma Acquires Sannova Analytical, Expanding cGMP Analytical And GLP Bioanalytical Services
- MVIC And Upperton Pharma Solutions Announce Strategic Collaboration
- All-In-One Solution For Continuous Microbial Monitoring Without Production Interruptions